亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

Efficacy and Safety of Doxepin 1 mg, 3 mg, and 6 mg in Adults with Primary Insomnia

作者
Thomas G. Roth,Roberta Rogowski,Steven G. Hull,Howard Schwartz,Gail Koshorek,Bruce C Corser,David Seiden,Alan Lankford
出处
期刊:Sleep [Oxford University Press]
卷期号:30 (11): 1555-1561 被引量:338
标识
DOI:10.1093/sleep/30.11.1555
摘要

STUDY OBJECTIVES: To evaluate the efficacy and safety of doxepin 1, 3, and 6 mg in insomnia patients. DESIGN: Adults (18-64 y) with chronic primary insomnia (DSM-IV) were randomly assigned to one of four sequences of 1 mg, 3 mg, and 6 mg of doxepin, and placebo in a crossover study. Treatment periods consisted of 2 polysomnographic assessment nights with a 5-day or 12-day drug-free interval between periods. Efficacy was assessed using polysomnography (PSG) and patient-reported measures. Safety analyses included measures of residual sedation and adverse events. MEASUREMENTS AND RESULTS: Sixty-seven patients were randomized. Wake time during sleep, the a priori defined primary endpoint, was statistically significantly improved at the doxepin 3 mg and 6 mg doses versus placebo. All three doses had statistically significant improvements versus placebo for PSG-defined wake after sleep onset, total sleep time, and overall sleep efficiency (SE). SE in the final third-of-the-night also demonstrated statistically significant improvement at all doses. The doxepin 6 mg dose significantly reduced subjective latency to sleep onset. All three doxepin doses had a safety profile comparable to placebo. There were no statistically significant differences in next-day residual sedation, and sleep architecture was generally clinically preserved. CONCLUSIONS: In adults with primary insomnia, doxepin 1 mg, 3 mg, and 6 mg was well-tolerated and produced improvement in objective and subjective sleep maintenance and duration endpoints that persisted into the final hour of the night. The side-effect profile was comparable to placebo, with no reported anticholinergic effects, no memory impairment, and no significant hangover/next-day residual effects. These data demonstrate that doxepin 1 mg, 3 mg, and 6 mg is efficacious in improving the sleep of patients with chronic primary insomnia.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
满意的平凡完成签到,获得积分10
2秒前
伶俐的秀发完成签到,获得积分10
3秒前
ChenYQ完成签到,获得积分10
29秒前
苹果完成签到 ,获得积分10
36秒前
殷勤的半凡完成签到,获得积分10
57秒前
耍酷的手套完成签到,获得积分10
1分钟前
1分钟前
1分钟前
充电宝的应助被爱学习的doge采纳,获得10
1分钟前
1分钟前
1分钟前
1分钟前
orixero的应助被爱学习的doge采纳,获得10
1分钟前
隐形曼青的应助被爱学习的doge采纳,获得10
1分钟前
在水一方的应助被爱学习的doge采纳,获得10
1分钟前
大模型的应助被爱学习的doge采纳,获得10
1分钟前
华仔的应助被爱学习的doge采纳,获得10
1分钟前
香蕉觅云的应助被爱学习的doge采纳,获得10
1分钟前
CodeCraft的应助被爱学习的doge采纳,获得10
1分钟前
SciGPT的应助被爱学习的doge采纳,获得10
1分钟前
隐形曼青的应助被爱学习的doge采纳,获得10
1分钟前
小二郎的应助被爱学习的doge采纳,获得10
1分钟前
852的应助被爱学习的doge采纳,获得10
1分钟前
1分钟前
田様的应助被爱学习的doge采纳,获得10
1分钟前
脑洞疼的应助被爱学习的doge采纳,获得10
1分钟前
bkagyin的应助被爱学习的doge采纳,获得10
1分钟前
顺利水桃完成签到,获得积分10
1分钟前
1分钟前
乐乐的应助被mengdewen采纳,获得10
1分钟前
1分钟前
1分钟前
1分钟前
1分钟前
1分钟前
1分钟前
1分钟前
1分钟前
1分钟前
1分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
Social Psychology in the Real World 600
八旗制度の研究 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8179924
求助须知:如何正确求助?哪些是违规求助? 9570159
关于积分的说明 21808379
捐赠科研通 7775767
什么是DOI,文献DOI怎么找? 3433193
关于科研通互助平台的介绍 2557347
邀请新用户注册赠送积分活动 2478918